The purpose of the present study was to determine whether chronic treatment with GLP-1 or the exenatide analog AC3174 has cardioprotective effects in a rat model of MI-induced CHF, to identify specific aspects of cardiac and metabolic function affected by GLP-1 or AC3174, and to evaluate some potential mechanisms for any observed effects. Here, GLP1R is linked to congestive heart failure.